Our portfolio company LUMA Vision, a leader in cardiac navigation and visualization, has successfully completed the first-in-human use of its VERAFEYE™ platform.
The VERAFEYE™ system combines state-of-the-art imaging technology with advanced maneuverability, enabling clinicians to capture highly detailed, four-dimensional images that update in real time. This allows for dynamic high-resolution navigation and visualization of the heart, crucial to performing today's advanced procedures.
Traditional imaging catheters provide only two-dimensional imaging, often limiting clinicians' ability to view cardiac anatomy from all angles during procedures. The VERAFEYE™ catheter introduces a new era of intracardiac imaging, allowing for comprehensive, 360-degree visualization with enhanced depth and clarity.
Fionn Lahart, CEO at LUMA Vision, expressed excitement about the technology's potential: "We are thrilled by this milestone and the future possibilities it opens for cardiac care. The development of VERAFEYE™ is a testament to our team's commitment to pushing the boundaries of medical technology and with imminent market approval, we can equip clinicians with the tools they need to achieve better outcomes for patients worldwide."
Read the full announcement on PR Newswire.